Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEResult▲ PositiveResults1 Aug 2026

Mangalam Global Enterprise Ltd

The Board of Directors at their Meeting held today i.e. on August 01, 2026 has inter alia, approved and adopted the standalone and consolidated Unaudited Financial Results of the Company ....

Mangalam Global Enterprise Ltd has announced its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The company reported a net profit of ₹752.93 crore, a 23% increase from the previous quarter's net profit of ₹616.08 crore. The results were reviewed and recommended by the Audit Committee and approved by the Board of Directors on August 1, 2026.

Read more →📎 1 attachment
BSECompany Update1 Aug 2026

Maral Overseas Ltd

Detailed disclosure attached

Maral Overseas Ltd is sending letters to shareholders whose email addresses are not registered with the company's RTA or Depository Participants, providing a web link to access the 37th AGM notice and annual report for FY 2025-26, and requesting them to update their email address, PAN, KYC, bank account details, and nomination details.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults1 Aug 2026

Aarti Drugs Ltd

Press Release on Q1FY27 Business and Financial Performance

Aarti Drugs Ltd reported its Q1FY27 business and financial performance, with revenue growing 19% YoY to Rs. 703.6 crore, EBITDA increasing 30% YoY to Rs. 96.9 crore, and EBITDA margin expanding 120 bps to 13.8%. The company's CFO & COO, Mr. Adhish Patil, attributed the strong performance to a mix of volume growth and improved realizations across its API & Speciality Chemicals portfolio, as well as disciplined execution.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change1 Aug 2026

SJVN Ltd

Enclosed

SJVN Ltd has announced changes in its senior management, with two officials promoted as Executive Directors and two others ceasing to be Senior Management due to superannuation.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults1 Aug 2026

SMS Pharmaceuticals Ltd

Investor Presentation

SMS Pharmaceuticals Ltd has released its Q1FY27 investor presentation, highlighting a 6% YoY revenue growth, sustained EBITDA margin of ~20%, and an 8% YoY PAT growth. The company has completed 4 DMF/CEP filings and is on track to meet its FY27 target of 10 filings. A ₹280 crore capex programme is progressing as planned, and the board has approved an infusion of up to ₹50 crore into its subsidiary SMS Peptides Private Limited.

Read more →📎 1 attachment
BSEAGM/EGMM&A1 Aug 2026

7NR Retail Ltd

Corrigendum to the notice of 14th Annual General Meeting enclosed herewith.

7NR Retail Ltd issued a corrigendum to the notice of its 14th Annual General Meeting, updating the valuation report, swap ratio, and details of the proposed allottees. The company will issue 9,00,00,000 equity shares to the allottees, with a swap ratio of 10:1. The equity shares are frequently traded, and the company is updating the current and proposed status of the allottees.

Read more →📎 1 attachment
← PreviousPage 2762 of 3475Next →